Aussie Change in Life-Saver Drugs Program Causes Many To Lose Access
This article was originally published in PharmAsia News
Executive Summary
Australia's drug-pricing system has not added a new drug to its Life Savings Drugs Program, which treats rare diseases in five years, and the program is set to see even more cuts over the next four years, leaving many with rare diseases unable to afford new treatments.